REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,968.00
Bid: 1,967.00
Ask: 1,969.00
Change: 8.00 (0.41%)
Spread: 2.00 (0.102%)
Open: 1,994.00
High: 2,000.00
Low: 1,959.00
Prev. Close: 1,960.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: BoE Stimuli Push Up Stocks But Depress Sterling

Thu, 04th Aug 2016 16:04

LONDON (Alliance News) - Stocks in London ended firmly in the green Thursday, while the pound took a big hit, after the Bank of England announced a substantial package of stimuli including an interest rate cut to a new record low and an expansion in asset purchases, after recent macroeconomic data had pointed to a slowdown in the UK economy following the Brexit referendum.

The BoE also drastically downgraded its growth projections as the Leave vote heightened uncertainty and the sharp depreciation in sterling triggered an upward revision to the inflation forecast.

The Monetary Policy Committee voted unanimously to cut UK interest rates by 25 basis points to 0.25%, the first rate cut since 2009. Governor Mark Carney said in a press conference following the decision that there is room for further cuts to rates, but made it clear that they will not go as low as to become negative.

"I'm not a fan of negative rate interest rates," Carney said, speaking to journalists. The governor signalled that the lower bound of rates will be close to zero, but always "a positive number".

Alongside the cut to rates, the central bank expanded the size of its Asset Purchase Facility programme, with the increase totalling GBP170 billion as a whole. Purchases of UK government bonds will increase by GBP60 billion to GBP435 billion. This measure was passed after the MPC voted 6-3, with policymakers Kristin Forbes, Ian McCafferty, and Martin Weale against the proposition, preferring no change.

The MPC also decided on the purchase of up to GBP10 billion of UK corporate bonds, with the decision approved with 8-1 majority.

In addition, the MPC voted unanimously to introduce a Term Funding Scheme that will be financed by the issuance of central bank reserves, aimed to help reinforce the transmission of the interest rate cut to the real economy. The BoE said this will operate as part of the asset purchasing programme.

The value of the lending in the TFS will be determined by usage of the scheme, the bank said, and could reach "around GBP100 billion". Carney added that UK banks have "no excuse" not to pass on the rate cut.

The governor said that, at this meeting, "everyone in the MPC though this economy needed stimulus". Carney noted that the Leave vote in the referendum represents a "regime change", but said the UK is "one of the most flexible economies in the world".

Oanda senior market analyst Craig Erlam said that, with this decision, "the BoE became one of the only central banks to announce a stimulus package that appears to have, at least for now, exceeded market expectations and satisfy investors in a way that other central banks have failed this year."

According to the Inflation Report released alongside the monetary policy decision, the economy is likely to see little growth in the second half of 2016. Business investment is set to continue to fall in the near term on slower demand growth. Gross domestic product growth is forecast to ease to 0.1% in the third quarter of 2016. The bank slashed its GDP growth outlook for 2017 to 0.8% from 2.3%. Similarly, the projection for 2018 was trimmed to 1.8% from 2.3%.

The fall in sterling is set to push up inflation in the near-term. Inflation is forecast to return to the 2% target in late 2017 and overshoot this target throughout 2018.

Sterling dropped immediately after the BoE's decision, having being quoted at USD1.3316 just prior. At the London equities close, the pound stood at 1.3138, compared to USD1.3327 at the same time Wednesday. The currency, however, remained way above the 31-year low of USD1.2797 reached in early July, with the results of the EU referendum still fresh.

Contrary to the pound, London stocks shot higher after the BoE decision, with the FTSE 100 index ending up 1.6%, or 105.76 points, at 6,740.16. The FTSE 250 of mid-caps rose 1.5%, or 247.19 points, to 17,244.32, and the AIM All-Share added 0.6%, or 4.33 points, to end at 761.66.

Aviva ended as the biggest blue-chip gainer, up 6.7%. The insurer's chief executive told journalists he is unsure about what an interest rate cut in the UK will achieve, after the blue-chip insurer had posted higher operating profit and hiked its dividend on a strong first half for its life and fund management businesses.

Aviva CEO Mark Wilson, speaking before the BoE's decision, said there is not currently a large amount of household debt in the UK and borrowing rates are already "incredibly cheap". Wilson was sanguine when questioned about any impact Aviva could face from interest rates remaining low or, indeed, falling further.

He said Aviva has been structured to ensure liabilities and assets move together, adding the group has "deliberately positioned" itself as a "blue-chip haven" against low interest rates.

Aviva declared an interim dividend of 7.42p, up from 6.75p a year prior, driven by strong performances in its life insurance and fund management operations. It said it remains on track to deliver on its plan to increase its dividend payout ratio to 50% of operating earnings per share by the end of 2017 from 42% in 2015.

RSA Insurance also reported first-half results, delivering a big rise in underwriting profit and declaring an increase in dividend. Underwriting profit for the first half increased 63% to GBP119.0 million from GBP73.0 million. This was driven by a 3.1 percentage point improvement in RSA's attritional loss ratio to 54.8% from 57.9%. The group declared an interim dividend of 5.0 pence per share, up 43% from 3.5p a year prior. RSA shares rose 1.4%.

Shares in Standard Chartered added 4.3% after Standard & Poor's Global upgraded the lender to Hold from Sell, while HSBC Holdings rose 2.5% after Merrill Lynch lifted its recommendation on the bank to Buy from Underperform, according to traders.

Hikma Pharmaceuticals missed the gains, ending as by far the worst blue-chip performer, down 17%. The drug company late Wednesday said it expects full-year operating profit within its Generics division to be hit by changes in revenue mix, but maintained its guidance on its other two divisions.

The company noted that it had experienced some delays in certain product approvals, but said the impact to revenue should be offset by higher contract manufacturing revenue. However, Hikma said the change in revenue mix is expected to hit profitability in 2016, along with higher than expected costs resulting from the acceleration in timing of certain pipeline-related litigation.

Hikma said it now expects core operating profit within its Generics division to come in within the range of USD30.0 million and USD40.0 million for 2016, below the USD46.0 million reported for 2015. Hikma was downgraded to Neutral from Buy by Citigroup and to Hold from Add by Numis.

In mainland Europe, the CAC 40 index in Paris the DAX 30 in Frankfurt both added 0.6%. At the equities close, the euro was quoted at USD1.1134, compared to USD1.1175 at the same time Wednesday.

In New York, stocks were higher at the European equities close, with the Dow 30 flat, and the S&P and the Nasdaq Composite both up 0.1%.

Gold was quoted at USD1.363.19 an ounce at the equities close, against USD1,357.14 on Wednesday, while Brent oil stood at USD43.30 a barrel, compared to USD42.47 on Wednesday.

Highlights in the economic calendar Friday are UK Halifax house prices at 0830 BST, and US nonfarm payrolls at 1330 BST. The US Baker Hughes US oil rig count is at 1800 BST.

In the UK corporate calendar, Royal Bank of Scotland Group, Ibstock, William Hill, Esure Group, and Kennedy Wilson Europe Real Estate all report half-year results. Bellway and S&U issue trading statements.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.